The delegates have decided that the wording of the interim decision to list the highest strength teeth whitening preparations in Appendix C is to be amended to remove the restriction "for direct in-clinic use". The delegates considered this to be too restrictive to dental practitioners in the exercise of their professional practice* and it did not accurately reflect the advice of the expert advisory committees. This approach was supported by all but one submission received during the consultation on the interim decision, with the exception of a wording change to reflect that the intent was not to limit the way dental practitioners use such products in exercising their professional practice.

In July 1972, the DPSSC decided to include vitamin D in Schedule 4 when the recommended daily dose exceeded 25 micrograms. This decision was based on the Canadian restrictions on vitamins A and D that drugs containing more than 10,000 international units of vitamin A in a recommended daily dose were prescription only and that the same restriction would apply to drugs containing more than 1,000 units of vitamin D in a recommended daily dose.
To our knowledge, this company collects reviews by asking its customers to share their experiences on Trustpilot. Read more This company has claimed its Trustpilot profile, but to our knowledge, doesn't actively invite its customers to write reviews on Trustpilot. Read more This company hasn't claimed its Trustpilot profile and to our knowledge, doesn't actively invite its customers to write reviews on Trustpilot. Read more
Prior to the 2008 Beijing Olympics, concerns were raised regarding cardarine which was creating significant and “remarkable” performance and endurance advantages without being regulated, so some athletes were potentially getting unfair advantages. While tests for cardarine weren’t developed in time for the Olympic Games, the following year PPARδ agonists (of which cardarine is included) were added to the WADA prohibited list.

The DAC technology in the CJC-1295 enables the compound to bind itself covalently with any circulating albumin, after it has been administered through a subcutaneous injection. However, the reason why the half-life could be extended from a few minutes to several days is more profound. The reactive group in the CJC-1295 binds to a peptide through bioconjugation. The peptide then finds a neucleophilic unit within the blood and reacts with it in order to create a firmer bond.

In February 1997, the National Drugs and Poisons Schedule Committee (NDPSC) decided to reschedule diclofenac dermal preparations (creams) containing 1 per cent or less of diclofenac from Schedule 4 to Schedule 2. This decision was based on the safety profile of a 1 per cent formulation and the then approved indications for use in readily recognised conditions (minor pain relief), which did not include treatment of solar keratosis.

Ipamorelin is a pentapeptide, meaning that it is composed of five amino acids, that mimics the body’s natural GH release.  Ipamorelin is a growth hormone releasing peptide (GHRP) and analogue of the hormone Ghrelin. It induces GH release and increases the number of somatarophs(cells responsible for GH release) in a GH pulse by suppressing somatostatin.

Various experiments have been conducted to test the effectiveness of CJC 1295-DAC in vivo and the Journal of Clinical Endocrinology & Metabolism has reported dose-dependent increases in mean plasma GH concentrations by 2-10 fold for more than 6 days and increased IGF-1 concentrations 1.5-3 fold for 9-11 days after a single injection. Mean half-life was shown to be 5.8-8.1 days, also after multiple doses mean IGF-1 levels remained above baseline for up to 28 days. No serious adverse reactions were reported in any group.

There is evidence of involvement of organised crime in supply of the substances. The substances are offered for sale via the internet. Many of the substances are promoted as safe alternatives to traditional performance enhancing substances such as the anabolic steroids. Suppliers are making unproven assertions about the efficacy and safety of the substances.

TGA evaluator concluded that the consistent absence of any clinically meaningful effects on blood pressure (BP) or heart rate (HR) in the applicant's bioavailability studies, and the absence of any ADR reports of BP, HR or other cardiovascular problems, indicate that "there is no valid reason for concern and no need to take any regulatory against the combination products currently in the ARTG and available in the Australian market", i.e. no demonstrated safety risk, and no evidence provided of efficacy of paracetamol 1000 mg / phenylephrine HCl 5 mg adult dose.
When dosing, an appropriate volume will be drawn from the vial with (typically) an insulin syringe, according to the desired dose and the concentration of the preparation. In the above example, a 100 mcg dose would require only 0.05 mL, or “5 IU” as marked on an insulin syringe. A 300 mcg would require 0.15 mL, or “15 IU” as marked on an insulin syringe.
In 1984, a synthetic hexapeptide, His-d-Trp-Ala-Trp-d-Phe-Lys-NH2 (GHRP-6), was identified by Bowers and colleagues. This hexapeptide was shown to potently stimulate GH release in vitro and in vivo by an unknown mechanism. Because of its poor oral bioavailability (0.3%) and short half-life (20 min) in human serum, GHRP-6 was selected only as a structural model to design a nonpeptide mimetic. Based on the structure–activity relationships (SARs) of GHRP-6, the nonpeptidyl growth hormone secretagogue (GHS) L-692,429 was identified by Smith et al. in 1993. This nonpeptidyl GHS synergizes with GHRP-6 to stimulate GH release and cAMP production, accompanied by a significant increase in intracellular calcium concentration ([Ca2 +]i), indicating that this nonpeptidyl GHS acts through a distinct signal transduction pathway. In 1995, a potent oral GHS L-163,191 (MK-0677) was reported by Patchett et al. This agent was found to have excellent oral bioavailability and specificity in its release of GH, without significant effect on plasma levels of other hormones such as aldosterone, luteinizing hormone, thyroxine, and prolactin.
Prior to the 2008 Beijing Olympics, concerns were raised regarding cardarine which was creating significant and “remarkable” performance and endurance advantages without being regulated, so some athletes were potentially getting unfair advantages. While tests for cardarine weren’t developed in time for the Olympic Games, the following year PPARδ agonists (of which cardarine is included) were added to the WADA prohibited list.

GHRP’s have been used whilst steroid cycling, but due to their nature and comparative weakness to steroids and the like, I find the best use of these compounds is during and after post cycle therapy in an attempt to keep as much of the steroid-induced gains as possible as well as helping the users mind-set as they still feel like they are ‘on’ something…sad but true. GHRP’s are also cycled in an alternate fashion with GH (and IGF), so as to keep the body’s natural GH production systems from de-sensitizing and shutting down completely…much in the same way that steroid users alternate HCG with steroids; to keep the natural testosterone system functioning optimally.
also using a dose of 400mcg for the IPAM is really a waste of your peptides as anything above saturation dose will give diminished returns, saturation dose(1mcg per kg) is a dose that will give maximum return, if you double the saturation dose then you will not get double the GH pulse in fact no where near that, then the more you use the less added benefit you will get.
Peptide therapy encompasses numerous different drugs with varied effects, ranging from immune modulation and tissue repair to fat loss and muscle building. Our center has seen very positive results in patients with CFS, Hashimoto’s thyroiditis, Lyme disease, and fibromyalgia, among other conditions. Ask your physician or speak to a patient representative at (877) 508-1177 to find out if peptide therapy is right for you.
The importance of limiting myocardial ischemia/reperfusion injury has been appreciated since Braunwald23,24 proposed that the extent and severity of tissue damage were not predetermined at the onset of ischemia, but could be modified by therapeutic manipulations applied during ischemia. Few years ago, a National Institutes of Health (NIH) expert’s panel concluded that cardioprotection is at a crossroads since approaches to identify cardioprotective therapies have been disappointing during the past 30 years.25 This may be related to the fact that the multiple candidates assayed so far target one single pathogenic event of the multiple damage cascade involved in myocardial damage and failure.25

CJC 1295 is a fast working growth hormone releasing hormones devised to reduce the effects of ageing. It works by stimulating the body’s natural growth hormone production and the release of IGF-1. The advantages of the CJC peptide is it helps increases bone density and collagen, as well as boosting the immune system. It will also produce new muscle cells which will be leaner and increases weight loss. The CJC 1295 results are part of years of scientific studies. It primarily increases the production of proteins, which leads to stable bodily functions related to the glands in the body or the endocrine system.


Growth hormone-releasing peptides (GHRPs) constitute a group of small synthetic peptides that stimulate the growth hormone secretion and the downstream axis activity. Mounting evidences since the early 1980s delineated unexpected pharmacological cardioprotective and cytoprotective properties for the GHRPs. However, despite intense basic pharmacological research, alternatives to prevent cell and tissue demise before lethal insults have remained as an empty niche in the clinical armamentarium. Here, we have rigorously reviewed the investigational development of GHRPs and their clinical niching perspectives.
The peptide therapy protocols (Amino Acid Analogs) prescribed by TeleWellnessMD providers are also known as secretagogues (pronounced se-creta-gog), a substance that promotes secretion. These amino acid chains communicate with the body to produce or release growth hormone. Hence a secretagogue causes the body’s own natural processes to produce growth hormone. Secretagogues do not act as growth hormones but rather stimulate the pituitary gland to secrete your stored growth hormone. The subcutaneous injection route of growth hormone stimulation is a preferred route to help slow down age and environmental reductions in growth hormone levels.
GHRH (Growth Hormone Releasing Hormones) cause the body to secrete a small amount of growth hormone. Depending upon the peptide, there can be short to long secreting times. Also, be aware that with most peptides there is a saturation dose (normally around 100mcg at a time). This means that going beyond the saturation dose will not produce an increase in growth hormone release. Experienced peptide users have indicated that saturation doses may actually be higher than 100mcg. However, this seems to depend on the purity of the peptides, and perhaps even based on the individual person themselves. In general, due to the nature of peptides, a lot of information has become anecdotal in nature rather than scientific.

Peptides are short chain amino acid monomers linked by a peptide bond. The body utilizes these short amino acids chains to secrete/pulse growth hormone (GH) that is already stored in your body. This is a very attractive option for those who are not able to utilize synthetic human growth hormone (HGH) naturally. In fact, this could even be a safer alternative for those seeking to use growth hormone for recovery, anti-aging and fat-loss. There are a multitude of peptides on the market and new ones being created almost monthly. Therefore, for the sake of an overview, let me just touch upon the ones that are most commonly used. To begin, let me start by first breaking down the two most important peptide groups for bodybuilding.


Cerebrolysin—also known as FPE 1070—is a synthetic nootropic drug. Nootropic drugs are substances that enhance cognitive functions such as memory, creativity, and motivation in otherwise healthy individuals. This peptide is extremely small, allowing it to penetrate the blood-brain barrier and act directly on the neurons of the central nervous system. Cerebrolysin has been found to improve the metabolic activity of brain tissue, shield neurons from harmful substances, and stimulate the peripheral and central nervous systems. In addition to its utility as a nootropic substance, the drug has potential as part of a treatment plan addressing Alzheimer’s disease, stroke, and moderate to severe head injury.


The search strategy was based on the PubMed/MEDLINE electronic databases including original research and review articles. The search was progressively date escalated from 1980 and included articles in English only. The search terms were as follows: growth hormone secretagogues (GHS), GHRP, growth hormone secretagogue receptor (GHS-R), CD36, cardiac ischemia/reperfusion, cardiac stunning, heart failure, cytoprotection, and cardioprotection.
If you’re ready to see differences in your workout regimen, you may be curious how muscle peptides are associated with lean muscle gain and strength building. As a locally owned and operated company, Muscle Peptides Australia is committed to helping our clients across Australia achieve their fitness goals. Contact us to unlock your body’s real potential.
GHRP-6 and all GHRP’s are mimetics of ghrelin, a hormone produced by cells of the stomach in response to a fasted condition, including brief fasts. Ghrelin and ghrelin mimetics work by activating the ghrelin receptor, also called the growth hormone secretagogue receptor (GHS-R1a). Elevated ghrelin levels act towards increasing GH levels by stimulation of ghrelin receptors in the pituitary.
The letters stand for ‘Growth Hormone Releasing Peptide’, and the compound is a peptide in the growth factor family, known as a HEXAPEPTIDE and GH SECRATAGOGUE. It has a strong effect on the release of endogenous (naturally produced) human growth hormone, in a dose related manner. It has been used in school medicine for the treatment of growth hormone deficiency in children and young adults, which drives home just how powerful this compound is at influencing the body to release its own natural GH. It works by signalling the pituitary gland to secrete GH itself, but also by the suppression of SOMATOSTATIN too (an antagonist of growth hormone releasing hormone – GHRH).
A peptide is an amino acid chain (amino acids being the building blocks of proteins), responsible for signalling different responses in the body. These amino chains already exist in the body in one form or another, which is why some consider them as ‘natural’ compounds (although testosterone exists in the human body too, adding extra is considered cheating in most cases). Peptides have been classified in research and manufacture according to a number sequence in many cases, which is why some are just numbers and letters (see later).
Increasing HGH release levels in your body naturally. It sounds too good to be true, but what if you could achieve just that by using a supplement? Using Ipamorelin alongside your exercise and diet regimen is going to help you achieve said goal. No two users are alike. For athletes or those who workout religiously, you might experience greater results than an individual who is overweight and just getting back into the gym after 10 years. So, take it with a grain of salt when detailing the results below. Dosage, your body composition, and other factors will play a role in the results you can expect to see when you incorporate Ipamorelin.
SARMS: Selective Androgen Receptor Modulator which means they are synthetic drugs that stimulate the androgen receptor for specific task such as muscle growth, fat loss and recovery. What makes SARMs so special is they don’t have heavy side effects like steroids, a good analogy commonly used to describe the difference is watering your garden. Sarms are a hose that target specific parts of the garden for specific results, steroids are a thunderstorm that water your garden as well, but blow over pots, flood the house and turn your lawn into a mudpit.
Unfortunately, as we age, the amount of growth hormone that is produced starts dropping, and into our 40’s it starts dropping off rapidly. This is where GHRP-6 can help a lot, as it mimics ghrelin in the body, which stimulates the ghrelin receptors. When this occurs, a signal is sent to the pituitary gland, increasing GH production. Another benefit of GHRP-6 is that it blocks out a hormone called somatostatin, which is the enemy of HGH secretion. Finally, there is evidence that GHRP-6 can have a positive effect on the nervous system by protecting neurons, giving the user a much higher overall wellness.

CJC-1295 increases the production of growth hormone as well as IGF-1 – which has anabolic effects in adults. However, it does not increase the levels of prolactin – high levels of which can create impotence and mental health problems in men. By increasing these two hormones, it enhances protein production in the body, which in turn, boosts muscle mass. It also induces lipolysis – the breakdown of fat tissue, boosts recovery from injuries, increases bone density, and also reduces aging factors like skin wrinkles. It can also stimulate cell growth, due to which it can be used to treat withered tissue or organs.
Combined, the loss of muscle and bone mass, is a quick ticket to the grave. The lack of supporting muscle and bone tissue, means that falls are more likely to occur, lengthy hospital stays inevitable, and the immobility created from these sustained injuries, produce further reduction in muscle mass and bone mass. A vicious cycle, which can be stopped in its tracks through the use of peptides such as SARMs.

A peptide is an amino acid chain (amino acids being the building blocks of proteins), responsible for signalling different responses in the body. These amino chains already exist in the body in one form or another, which is why some consider them as ‘natural’ compounds (although testosterone exists in the human body too, adding extra is considered cheating in most cases). Peptides have been classified in research and manufacture according to a number sequence in many cases, which is why some are just numbers and letters (see later).

Cancer can often be a process of uncontrolled cellular division. IGF-1 is not only pro-growth in a way that could increase this cellular division, but IGF-1 also inhibits apoptosis, or programmed cell death. Hence the theory among some in the medical community that tumors could increase synthesis of IGF-1 to keep themselves alive and to encourage the spread of cancer throughout the body. This doesn’t mean that IGF-1 directly causes cancer.
For example, there are Growth Hormone Releasing Peptides (GHRP’s with names such as ipamorelin and hexarein) which allow for a slow and steady growth hormone release that produces a pulse which mimics natural growth hormone release times and Growth Hormone Releasing Hormones (GHRH’s such as Mod-GRF) for an even stronger natural release of growth hormone and greater presence of growth hormone precursors known as GH “frags” or fragments.
The use of peptides is not necessarily a case of one or the other. While you can derive benefit from using either GHRH or GHRP, the effects can be amplified by using both. This, for one, will help to better keep levels of somatostatin under control. The amount of that hormone is an issue you will be forced to contend with when using only GHRH. This is because it is known to inhibit growth hormone.
Figure 6: Microscopic aspect of the rabbits’ ears wounds. (a) Representative image of “nipple” in which, above the cartilage and the perichondrium, there is a prominent accumulation of extracellular matrix. (b) Representative image of the effect induced by the GHRP-6 intervention. Note the reduction of extracellular matrix accumulation within the injured area. The “flattening” aspect is indicated by the solid line arrow. The dotted arrows indicate that the elevation within the center of the scar is similar to the adjacent intact skin. Images suggest that GHRP-6 reduced the local hypercellularity associated with the cartilage cells response. H/E 10x magnification.

Manipulation of somatostatin tone also affects the GH response to GHSs. When hexarelin was given to subjects in combination with somatostatin, the amount of GH released was significantly reduced. When arginine, a postulated inhibitor of somatostatin, was administered to older adults, a group proposed to have increased somatostatin tone, GH levels following the administration of GHRP-6 increased significantly, to levels seen in younger subjects.
Intestinal Growth: A potential problem often mentioned in association with IGF-1, however the large distended stomachs seen on professional bodybuilders are generally a result of over-dosing on Human Growth Hormone (HGH) rather than the usage of IGF-1. No anecdotal reports have been made by users of IGF-1 LR3 relating to growth of the gut so it is of little concern. Please ensure that you stick to our recommended doses and you will not have any issues.
Following the preliminary histological data, suggesting a reduction of wound inflammation and a far more organized ECM, we addressed the gene expression study toward inflammatory and profibrogenic markers. We primarily examined Cd36 expression following topical GHRP-6 application and found that peptide reduced its receptor expression () (Figure 4). Furthermore, the treatment significantly reduced Adam17 expression () and approached to significantly reduce Tnf (), which may partially contribute to explaining the substantial reduction of infiltrated inflammatory cells within the wound bed (Figure 4).

This particular peptide offers therapeutic benefits similar to those of hGH. CJC 1295 is a growth hormone releasing hormone (GHRH) analogue. In other words, it is a molecule that serves the same purpose as does GHRH—the hormone that stimulates the anterior pituitary to release hGH. However, unlike GHRH, which has a half-life of only minutes after IV administration, CJC 1295 is able to remain active in the body for extended periods due to its ability to bind to a protein in the blood known as albumin and avoid degradation by various enzymes. CJC 1295 increases an important growth factor, IGF-1, in addition to hGH, leading to fat loss, lean muscle growth, and enhanced sleep.
It has been previously explained that some individuals will elect to administer GHRP-6 doses twice daily, and some more than three times daily. Twice daily administration of at least 100mcg (typically upon awaking and before sleeping) will yield anti-aging and general health benefits. 3 times daily administration should yield general health benefits, fat loss, and muscle gain. 4 times daily or greater administration should provide more pronounced muscle gains and fat loss.

Our group has contributed to validate the potential antifibrotic abilities of GHRP-6 in animal models of liver cirrhosis38 and hypertrophic scars,39 in which via a peroxisomal proliferator-activated receptor gamma (PPARγ)-driven cascade, GHRP-6 intervention reduced TGF-β1 and connective tissue growth factor (CTGF) expression, which translated in a dramatic reduction in the accumulation of collagen and other extracellular matrix (ECM) proteins.
×